Takeda Pharmaceutical Co. Ltd., 10% Owner at Phathom Pharmaceuticals, Inc. (PHAT), sold 53,111 shares at $37.47 ($2.0M) on 2021-05-04, disclosed to the SEC on 2021-05-05.
Open-market sale of $2.0M PHAT by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.60 | 3,157 | $119K | 6.0% |
| 2 | $37.60 | 3,157 | $119K | 6.0% |
| 3 | $38.45 | 11,272 | $433K | 21.9% |
| 4 | $38.45 | 11,272 | $433K | 21.9% |
| 5 | $39.06 | 203 | $8K | 0.4% |
| 6 | $35.50 | 11,070 |
| $393K |
| 19.8% |
| 7 | $36.21 | 4,690 | $170K | 8.6% |
| 8 | $36.21 | 4,690 | $170K | 8.6% |
| 9 | $37.47 | 3,500 | $131K | 6.6% |
| 10 | $38.53 | 100 | $4K | 0.2% |
| Total | $37.28 avg | 53,111 | $2.0M | 100% |
| Filing → |
| DAWN | SELL | 2021-12-09 | $9.9M | — | Filing → |
| PHAT | SELL | 2021-11-08 | $20.9M | — | Filing → |
| PHAT | SELL | 2021-07-09 | $183K | — | Filing → |